Results 161 to 170 of about 18,764 (290)

Ascites of patients with solid tumors shows distinct inflammatory patterns

Cancer Communications, Volume 45, Issue 8, Page 936-940, August 2025.
Julia M. Berger, Martin Korpan, Carina Zierfuss, Katharina Syböck, Erwin Tomasich, Andreas Kienzle, Maria Koenig, Markus Kleinberger, Lynn Gottmann, Birgit Fendl, Cihan Ay, Johannes Pammer, Catharina Müller, Rudolf Oehler, Lorenz Balcar, Thomas Reiberger, Elisabeth S. Bergen, Barbara Niederdorfer, Matthias Preusser, Anna S. Berghoff   +19 more
wiley   +1 more source

Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy.

Nano letters (Print), 2019
Currently, various oncolytic adenoviruses (OA) are being explored in both preclinical and clinical virotherapy. However, the pre-existing neutralizing antibodies (nAbs) and poor targeting delivery are major obstacles for systemically administered OA ...
Peng Lv, Xuan Liu, Xiaomei Chen, Chao Liu, Yang Zhang, Chengchao Chu, Junqing Wang, Xiaoyong Wang, Xiaoyuan Chen, G. Liu   +9 more
semanticscholar   +1 more source

How do changes in tumor matrix affect the outcome of virotherapy? [PDF]

, 2007
Jin Q. Cheng, Harald Sauthoff, John G. Hay   +2 more
openalex   +1 more source

Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

Frontiers in Immunology
Onco-virotherapy is an emergent treatment for cancer based on viral vectors. The therapeutic activity is based on two different mechanisms including tumor-specific oncolysis and immunostimulatory properties.
Hélène Lê, Hélène Lê, Jules Deforges, Pasquale Cutolo, Anissa Lamarque, Guoqiang Hua, Véronique Lindner, Véronique Lindner, Shreyansh Jain, Jean-Marc Balloul, Nadia Benkirane-Jessel, Eric Quéméneur   +11 more
doaj   +1 more source

Decreasing the Susceptibility of Malignant Cells to Infection Does Not Impact the Overall Efficacy of Myxoma Virus-Based Oncolytic Virotherapy [PDF]

, 2020
Erica Flores, Eric Bartee
openalex   +1 more source

Effects of Newcastle Disease Virus on Gene Expression Profiling, and Nitric Oxide and Glutathione Production in MCF-7 Breast Canser Cell Line [PDF]

, 2011
Breast cancer is a major cause of death for many women around the world. Progress has been made in the survival of breast cancer patients due to improved understanding of the molecular processes, diagnostic techniques and knowledge of the treatment using
Ali, Mohamed Kalid
core  

Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial

Nature Medicine, 2023
H. Soliman, D. Hogue, H. Han, Blaise Mooney, R. Costa, Marie Catherine Lee, B. Niell, Angela Williams, A. Chau, Shannon Falcon, A. Soyano, Avan J Armaghani, N. Khakpour, R. Weinfurtner, S. Hoover, J. Kiluk, C. Laronga, M. Rosa, H. Khong, B. Czerniecki   +19 more
semanticscholar   +1 more source

Cooperation of oncolytic virotherapy with VEGF-neutralizing antibody treatment in IDH wildtype glioblastoma depends on MMP9 [PDF]

, 2019
Hans‐Georg Wirsching, Sonali Arora, Huajia Zhang, Frank Szulzewsky, Patrick J. Cimino, Christophe Quéva, A. McGarry Houghton, Joseph C. Glorioso, Michael Weller, Eric C. Holland   +9 more
openalex   +1 more source

Experimental treatment modalities for osteosarcoma: Preclinical studies on virotherapy, chemotherapy and small molecule therapy [PDF]

, 2008
Kaspers, G.J.L. [Promotor]Wuisman, P.I.J.M. [Promotor]Beusechem, V.W.
Graat, H.C.A.
core   +2 more sources

Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy [PDF]

, 2010
Paul T. Sobol, Jeanette E. Boudreau, Kyle B. Stephenson, Yonghong Wan, Brian D. Lichty, Karen Mossman   +5 more
openalex   +1 more source